Insider · CIK 0001276361

Alta Partners II Inc

CIK 0001276361 Name as filed on the most recent filing

Filed as Alta Partners II Inc (20)

47 transaction lines · from 20 filings · filed 2004-02-23 to 2009-10-20 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2009-10-16 P, Open-market purchase Corcept Therapeutics IncCORT 2 lines 482,518, acquired Open Form 4 filing 0001209191-09-049303
2009-10-16 P, Open-market purchase Corcept Therapeutics IncCORT 2 lines 482,518, acquired Open Form 4 filing 0001209191-09-049267
2008-03-25 P, Open-market purchase Corcept Therapeutics IncCORT 2 lines 2,933,804, acquired Open Form 4 filing 0001209191-08-020303
2006-11-07 S, Open-market sale Occam Networks Inc/DEOCNW Not reported Open Form 4 filing 0001209191-06-058251
2005-10-14 S, Open-market sale Cotherix IncCTRX 3 lines 2,170,181, disposed Open Form 4 filing 0001209191-05-052704
2005-10-12 S, Open-market sale Cotherix IncCTRX 3 lines 3,215,082, disposed Open Form 4 filing 0001209191-05-052406
2004-10-15 P, Open-market purchase Cotherix IncCTRX 2,150,556, acquired Open Form 4 filing 0001209191-04-049146
2004-10-15 P, Open-market purchase Cotherix IncCTRX 2,499,996, acquired Open Form 4 filing 0001209191-04-048862
2004-05-07 S, Open-market sale Rigel Pharmaceuticals IncRIGL 2 lines 66,650, disposed Open Form 4 filing 0001209191-04-024765
2004-05-03 S, Open-market sale Rigel Pharmaceuticals IncRIGL 2 lines 2,028,398, disposed Open Form 4 filing 0001209191-04-023682
2004-04-30 S, Open-market sale Rigel Pharmaceuticals IncRIGL 2 lines 178,500, disposed Open Form 4 filing 0001209191-04-022995
2004-04-29 S, Open-market sale Rigel Pharmaceuticals IncRIGL 2 lines 739,514, disposed Open Form 4 filing 0001209191-04-022845
2004-04-28 S, Open-market sale Rigel Pharmaceuticals IncRIGL 2 lines 170,000, disposed Open Form 4 filing 0001209191-04-022845
2004-04-27 S, Open-market sale Rigel Pharmaceuticals IncRIGL 2 lines 153,038, disposed Open Form 4 filing 0001209191-04-022316
2004-04-26 S, Open-market sale Rigel Pharmaceuticals IncRIGL 2 lines 36,142, disposed Open Form 4 filing 0001209191-04-022316
2004-04-23 S, Open-market sale Rigel Pharmaceuticals IncRIGL 2 lines 279,285, disposed Open Form 4 filing 0001209191-04-021816
2004-04-22 S, Open-market sale Rigel Pharmaceuticals IncRIGL 2 lines 40,375, disposed Open Form 4 filing 0001209191-04-021729
2004-04-21 S, Open-market sale Rigel Pharmaceuticals IncRIGL 2 lines 146,747, disposed Open Form 4 filing 0001209191-04-021729
2004-04-07 S, Open-market sale Rigel Pharmaceuticals IncRIGL 2 lines 1,266,342, disposed Open Form 4 filing 0001209191-04-020086
2004-04-06 S, Open-market sale Rigel Pharmaceuticals IncRIGL 2 lines 203,700, disposed Open Form 4 filing 0001209191-04-019836
2004-04-05 S, Open-market sale Rigel Pharmaceuticals IncRIGL 2 lines 27,540, disposed Open Form 4 filing 0001209191-04-019836
2004-03-24 S, Open-market sale Rigel Pharmaceuticals IncRIGL 2 lines 149,740, disposed Open Form 4 filing 0001209191-04-017682
2004-02-19 S, Open-market sale Rigel Pharmaceuticals IncRIGL 2 lines 1,489,280, disposed Open Form 4 filing 0001209191-04-017676
2004-02-19 S, Open-market sale Rigel Pharmaceuticals IncRIGL 2 lines 2,233,920, disposed Open Form 4 filing 0001209191-04-012112

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. ALTA PARTNERS II INC, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001276361

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.